ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.771,88
0,00%
S&P 500
5.872,16
-2,95%
US Dollar vs BRL
6,27854
-0,19%
Bitcoin
102.418,58
2,35%
Brent Oil
72,965
0,32%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aethlon Medical Inc (AEMD)

  7. Aethlon Medical Inc (AEMD) Notícias

AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEMD
DataHoraFonteTítuloCódigoCompanhia
15/11/202418:40Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AEMDAethlon Medical Inc
13/11/202419:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
13/11/202418:15PR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
12/11/202411:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
11/11/202410:01PR Newswire (US)Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in AustraliaNASDAQ:AEMDAethlon Medical Inc
06/11/202410:01PR Newswire (US)Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024NASDAQ:AEMDAethlon Medical Inc
08/10/202409:01PR Newswire (US)Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:AEMDAethlon Medical Inc
01/10/202418:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
19/09/202409:01PR Newswire (US)Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in IndiaNASDAQ:AEMDAethlon Medical Inc
16/09/202409:01PR Newswire (US)Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
13/09/202409:35GlobeNewswire Inc.Aethlon Medical to Present at the Life Sciences Investor Forum September 19thNASDAQ:AEMDAethlon Medical Inc
27/08/202409:01PR Newswire (US)Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor KidneysNASDAQ:AEMDAethlon Medical Inc
15/08/202417:34Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AEMDAethlon Medical Inc
15/08/202417:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AEMDAethlon Medical Inc
15/08/202417:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AEMDAethlon Medical Inc
15/08/202417:15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:AEMDAethlon Medical Inc
14/08/202417:15PR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
12/08/202409:01PR Newswire (US)Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
06/08/202410:12PR Newswire (US)Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024NASDAQ:AEMDAethlon Medical Inc
27/06/202417:15PR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
21/06/202409:01PR Newswire (US)Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024NASDAQ:AEMDAethlon Medical Inc
18/06/202409:01PR Newswire (US)Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
03/06/202409:01PR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
17/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
16/05/202417:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:AEMDAethlon Medical Inc
15/05/202410:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEMDAethlon Medical Inc
15/05/202410:15PR Newswire (US)Aethlon Medical Announces Pricing of $4.7 Million Public OfferingNASDAQ:AEMDAethlon Medical Inc
13/05/202418:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AEMDAethlon Medical Inc
10/05/202409:01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
21/02/202410:01PR Newswire (US)Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesNASDAQ:AEMDAethlon Medical Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEMD

Seu Histórico Recente

BIT
I06744
Intesa Sanpaolo
BIT
OIL2L
Wti Crude Oil 2x Daily L...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados